Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceuticals products in China and internationally. The company offers synthetic vitamin E, vitamin A, natural vitamin E, ß-carotene, canthaxanthin, vancomycin hydrochloride, teicoplanin, and daptomycin. It also provides fat-soluble vitamins, quinolone antibiotics, anti-drug-resistant antibiotics, and other products, as well as animal nutrition products. In addition, the company offers injectable levofloxacin lactate, vancomycin hydrochloride injection, and injectable teicoplanin products. The company was incorporated in 1997 and is headquartered in Shaoxing, China.
Frequently asked questions
What sector does Zhejiang Medicine Co Ltd (600216) operate in?
Zhejiang Medicine Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Zhejiang Medicine Co Ltd (600216) current stock price?
As of the latest data, Zhejiang Medicine Co Ltd stock price is CN¥12.55, with a previous close of CN¥12.55.
What is Zhejiang Medicine Co Ltd (600216) current market capitalization?
Zhejiang Medicine Co Ltd market cap is approximately 12.07 billion.
What is Zhejiang Medicine Co Ltd (600216) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.84, and the forward EPS is CN¥1.23.
What is Zhejiang Medicine Co Ltd (600216) Price-to-Earnings (P/E) ratio?
Zhejiang Medicine Co Ltd current P/E ratio is 14.94, with a forward P/E of 10.24.
Does Zhejiang Medicine Co Ltd (600216) pay dividends?
No. Zhejiang Medicine Co Ltd does not pay a dividend.
What is Zhejiang Medicine Co Ltd (600216) beta (volatility) score?
Zhejiang Medicine Co Ltd has a beta of 0.319, indicating lower volatility than the overall market.
